This website uses cookies to improve your online experience. They are placed on your computer when you launched this website. You can change your cookie settings through your browser. If you continue to use this site, you consent to our use of cookies. Privacy Notice.

Walbrook home page

Current News

2023

Walbrook PR – ILC Therapeutics

Walbrook PR, which provides high quality Strategic communications and Investor Relations support to Small and AIM listed companies, announces it is acting as corporate communications advisor for ILC Therapeutics, a Scottish based biotechnology company developing an exciting novel drug class.

01 August 2023  •  Read more

Walbrook PR – SigmaRoc Plc

Walbrook PR, which provides high quality Financial PR and Investor Relations services to Small Cap and AIM listed companies, announces that it is acting as Financial PR & Investor Relations advisor for SigmaRoc plc (AIM: SRC), the specialist quarrying group that invests, improves, integrates and innovates companies within the industrial materials space, in both the UK and Europe.

17 July 2023  •  Read more

Walbrook PR - Inspiration Healthcare

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces it is acting as Financial PR & Investor Relations advisor for Inspiration Healthcare Group plc (AIM: IHC), a leading developer and manufacturer, with a focus on pioneering best-in-class, specialist neonatal intensive care medical devices.

12 April 2023  •  Read more

Walbrook PR – Novacyt Group

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces it is acting as Financial PR & Investor Relations advisor for Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international diagnostics business generating an increasing portfolio of in vitro and molecular diagnostic tests.

12 April 2023  •  Read more

Walbrook PR - Victoria Plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces it is acting as Financial PR & Investor Relations advisor for Victoria plc (LSE: VCP), an international manufacturer and distributor of innovative flooring products.

12 April 2023  •  Read more

Anna Dunphy, Lianne Applegarth and Nick Rome

Huge congratulations to Anna Dunphy, Lianne Applegarth and Nick Rome on their recent promotions to Director.

12 April 2023  •  Read more

Alice Woodings

Huge congratulations to Alice Woodings on her promotion to Associate Director.

12 April 2023  •  Read more

2022

Walbrook PR - Zamaz plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces it is acting as Financial PR & Investor Relations advisor for Zamaz plc (LSE:ZAMZ), the on-line consumer goods business that originates, acquires or licenses, operates and scales small and medium-sized brands with category-winning products on global marketplaces; with a focus on ecologically produced, ethically, and health supportive brands and products. Walbrook is managing the Company’s ongoing communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

20 September 2022  •  Read more

Louis Ashe-Jepson

Congratulations to Louis Ashe-Jepson on his recent promotion to Senior Associate

04 July 2022  •  Read more

Walbrook PR - Spectral MD

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, congratulates its client Spectral MD Holdings, Ltd. (AIM: SMD) on their win of the Best Technology Award at the European Mediscience Awards 2022 on 16 June 2022.

04 July 2022  •  Read more

Walbrook PR AQSE IPO – ProBiotix Health PLC

Walbrook PR, one of the UK’s leading providers of Financial PR and Investor Relations to Small Cap and AIM listed companies, announces it has acted as Financial PR & Investor Relations advisor for the Aquis Stock Exchange (“AQSE”) IPO of ProBiotix Health plc (“ProBiotix”), the life sciences business developing probiotics to tackle cardiovascular disease and other lifestyle conditions. ProBiotix was established by AIM-listed OptiBiotix Health plc to develop next-generation microbiome solutions for a wide range of health conditions and to deliver commercially successful products supported by a strong scientific evidence base.

31 March 2022  •  Read more

2021

Walbrook PR Welcomes Light Science Technologies Holdings to AIM

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces it is acting as Financial PR & Investor Relations advisor for Light Science Technologies Holdings plc (AIM: “LST”), the controlled environment agriculture (“CEA”) technology and contract electronics manufacturing (“CEM”) Group. Having advised the Company ahead of its successful IPO on AIM last month, Walbrook is now managing the Company’s ongoing communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

16 November 2021  •  Read more

Walbrook PR closes in on pole position in AIM adviser rankings

Walbrook PR, one of the UK’s leading providers of Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its rise to second place in the AIM adviser rankings by most financial PR clients listed on the London Stock Exchange’s AIM market, according to the latest quarterly report from Adviser Rankings.

01 November 2021  •  Read more

Walbrook PR Appointed by Pittards plc

Walbrook PR, one of the UK’s leading providers of Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as PR & IR advisor to Pittards plc (“Pittards”), the specialist producer of technically advanced leather and luxury leather goods for retailers, manufacturers and distributors. The team at Walbrook will manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

01 September 2021  •  Read more

WALBROOK PR Appointed By Abingdon Health plc

Walbrook PR, one of the UK’s leading providers of Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as PR & IR advisor to Abingdon Health plc (“Abingdon”), a leading international developer and manufacturer of high quality and effective rapid tests. The team at Walbrook will manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

09 August 2021  •  Read more

Walbrook PR Welcomes GENinCode to AIM

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces it has acted as Financial PR & Investor Relations advisor for the AIM IPO of GENinCode plc (AIM: “GENI”), the cardiovascular disease ("CVD") company focused on predictive genetics for the prevention of cardiovascular disease. The team at Walbrook will now manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

22 July 2021  •  Read more

WALBROOK PR Welcomes Spectral MD To AIM

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces it has acted as Financial PR & Investor Relations advisor for the AIM IPO of Spectral MD Holdings, Ltd. (AIM: “SMD”), a predictive analytics group that develops proprietary AI algorithms and optical technology for faster treatment decisions in wound care. The team at Walbrook will now manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

22 June 2021  •  Read more

WALBROOK PR Welcomes Belluscura To AIM

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces it has acted as Financial PR & Investor Relations advisor for the AIM IPO of Belluscura plc (AIM: “BELL”), a leading medical device developer focused on lightweight and portable oxygen enrichment technology. The team at Walbrook will now manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

28 May 2021  •  Read more

Walbrook PR Appointed By Nuformix plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to Nuformix plc (LSE:NFX), a pharmaceutical development company and drug repurposing specialist. The team at Walbrook will manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

01 May 2021  •  Read more

WALBROOK PR Appointed By Hargreaves Services plc

Walbrook PR, one of the UK’s leading providers of Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as PR & IR advisor to Hargreaves Services plc (“Hargreaves”), a diversified group delivering services to the industrial and property sectors. The team at Walbrook will manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

01 April 2021  •  Read more

Walbrook PR Appointed by Induction Healthcare Group plc

Walbrook PR, one of the UK’s leading providers of Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as PR & IR advisor to Induction Healthcare Group plc (“Induction”), a leading healthcare technology company that helps to digitally transform hospitals. The team at Walbrook will manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

05 March 2021  •  Read more

Walbrook PR Appointed By Reneuron Group Plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics. The team at Walbrook will manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

01 March 2021  •  Read more

Walbrook PR Appointed By NetScientific plc

Walbrook PR, one of the UK’s leading providers of Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as PR & IR advisor to NetScientific plc (“NetScientific”), the international investment and commercial advisory group for the life sciences and sustainability technology sectors. The team at Walbrook will manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

01 January 2021  •  Read more

Walbrook PR Appointed By Tissue Regenix Group plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to AIM listed Tissue Regenix Group plc, the regenerative medical devices company. The team at Walbrook will manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

01 January 2021  •  Read more

2020

Walbrook PR AIM IPO - Intuitive Investments Group plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces that it has acted as Financial PR & Investor Relations advisor to the recent AIM IPO of Intuitive Investments Group plc, the closed-end investment company focused on the life sciences sector. The team at Walbrook will now manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

14 December 2020  •  Read more

Walbrook PR appointed by Open Orphan plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to AIM and Euronext listed Open Orphan plc, a rapidly growing specialist pharmaceutical services CRO which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials. The team at Walbrook will manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

01 December 2020  •  Read more

Walbrook PR AIM IPO Autumn Brace Sourcebio International Plc & Verici Dx Plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces that is has acted as Financial PR & Investor Relations advisor to two recent AIM IPOs: SourceBio International plc, a leading international provider of integrated state-of-the-art laboratory services and products, and Verici Dx plc, a developer of advanced clinical diagnostics for organ transplant. The team at Walbrook will now manage ongoing communications with the financial media, research analysts and non-institutional investors, including new and existing private investors for both companies.

19 November 2020  •  Read more

Walbrook PR appointed by Feedback PLC

Walbrook PR, one of the UK’s leading providers of Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as PR & IR advisor to Feedback plc (“Feedback”), the specialist medical imaging technology company.

27 October 2020  •  Read more

Paul McManus, MD of Walbrook PR, writes for the Yorkshire Post

Long live the new-look AGM

06 October 2020  •  Read more

Paul McManus, MD of Walbrook PR, writes for the Yorkshire Post

Going online in lockdown has levelled the playing field for investors

02 October 2020  •  Read more

Walbrook PR appointed by Van Elle Holdings PLC

Walbrook PR Limited, one of the UK’s leading providers of Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to AIM listed Van Elle Holdings plc (Van Elle), the UK-based provider of first-class ground engineering services and the largest contractor in their industry since 2018. The team at Walbrook will manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

14 September 2020  •  Read more

Walbrook PR appointed by Truspine Technologies plc for AQSE listing

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces that it has acted as Financial PR & Investor Relations advisor to Truspine Technologies plc during their recent listing on the Aquis Stock Exchange (AQSE). Truspine Technologies plc is a medical device company focused on the USD$10.2 billion per annum spinal (vertebral) stabilisation market. Truspine raised gross proceeds of £1.4 million and was valued at £31.6 million on Admission to AQSE.

20 August 2020  •  Read more

Walbrook PR supports trio of stock exchange admissions

Walbrook PR Limited, one of the UK’s leading providers of Financial PR and Investor Relations to Small Cap and AIM listed companies, announces that it has supported the admissions of three companies to the UK’s public stock markets since the turn of the year.

20 May 2020  •  Read more

Paul McManus, MD of Walbrook PR, writes for the Yorkshire Post

AIM's companies show "Dunkirk Spirit" to battle pandemic

14 May 2020  •  Read more

Walbrook PR appointed by IXICO plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to AIM listed IXICO plc

01 May 2020  •  Read more

Paul McManus, MD of Walbrook PR, writes for the Yorkshire Post

AIM's spirits are being revived

06 February 2020  •  Read more

2019

Walbrook PR appointed by Concepta plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to AIM listed Concepta plc.

13 November 2019  •  Read more

Creo Medical win at the AIM Awards 2019

Congratulations Creo Medical plc for winning the Best Technology Award at the AIM Awards 2019.

11 October 2019  •  Read more

Renalytix AI/EKF Diagnostics win at the AIM Awards 2019

11 October 2019  •  Read more

Walbrook PR appointed by Evgen Pharma Plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to AIM listed Evgen Pharma Plc.

01 September 2019  •  Read more

Walbrook PR appointed by Yourgene Health plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to AIM listed Yourgene Health plc ("Yourgene").

18 July 2019  •  Read more

Paul McManus, MD of Walbrook PR, writes for the Yorkshire Post

"How to handle a profit warning and keep calm"

07 February 2019  •  Read more

Walbrook PR appointed by genedrive plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to AIM listed genedrive plc.

22 January 2019  •  Read more

Walbrook PR appointed by Shield Therapeutics Plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to AIM listed Shield Therapeutics Plc ("Shield").

01 January 2019  •  Read more

2018

2016

Walbrook PR appointed by Venture Life Group plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to AIM listed Venture Life Group plc in July 2016. The Company is an international consumer self-care group focused on developing, manufacturing and commercialising products for the ageing population.

01 July 2016  •  Read more

Walbrook PR appointed by AIM listed eSports player Gfinity plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR adviser to Gfinity plc, the AIM listed eSports specialist.

01 May 2016  •  Read more

Walbrook PR appointed by MedaPhor Group plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment to AIM listed MedaPhor Group plc, the global provider of advanced ultrasound education simulators for medical professionals.

01 May 2016  •  Read more

Walbrook PR appointed by Milestone Group

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to AIM listed Milestone Group plc ("Milestone").

28 April 2016  •  Read more

Walbrook PR appointed by Healthperm Resourcing Ltd

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment to Healthperm Resourcing Ltd, the healthcare recruitment business which has been established to address the significant shortfalls in healthcare professionals in the UK and UAE.

01 March 2016  •  Read more

Walbrook PR appointed by Motif Bio & Surgical Innovations

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to AIM listed Motif Bio plc, which specialises in developing novel antibiotics, and Surgical Innovations Group plc, which designs and manufactures innovative medical technology for minimally invasive surgery.

16 February 2016  •  Read more

2015

Walbrook PR's IPO Brace: Bluebird & Be Heard

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR advisor to BlueBird Merchant Ventures Ltd, a minerals company with assets in the Philippines, and Be Heard group plc, which is building a network of digital companies spanning the marketing services, technology and e-commerce sectors across the UK, the US and Europe.

18 November 2015  •  Read more

Walbrook PR locks up Mortice account

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to AIM listed Mortice Limited ("Mortice"), which focusses on the Security and Facilities Management market in India.

30 July 2015  •  Read more

Walbrook PR hires Gary Middleton

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces that Gary Middleton has joined the Walbrook team as a full-time Consultant to support the growth of Walbrook's natural resources offering.

17 July 2015  •  Read more

Walbrook PR advises on AIM IPO Satellite Solutions Worldwide Group plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to Satellite Solutions Worldwide Group plc ("SSW") having worked on the Company's recent IPO which raised £2.25m and saw the satellite broadband business join AIM with an initial valuation of just under £14m. Walbrook will manage communications with the financial media, research analysts and investors on behalf of SSW.

19 May 2015  •  Read more

Walbrook PR advises on Curtis Banks Group plc AIM IPO

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR advisor to specialist SIPP administrator Curtis Banks Group Plc, to manage communications with the financial media, research analysts and investors surrounding its forthcoming Placing to raise £7.5m and Admission to AIM.

29 April 2015  •  Read more

Merger of Winningtons with Walbrook PR

Walbrook PR, which provides high quality Financial PR and Investor Relations advice to Small Cap and AIM listed companies, has agreed a merger with Winningtons Financial Public Relations Ltd. ("Winningtons") that will see Walbrook PR ("Walbrook") become the second largest Financial PR Adviser by number of AIM listed clients.

08 April 2015  •  Read more

2014

Walbrook PR appointed as financial PR to Frenkel Topping Group Plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR advisor to AIM listed financial services company Frenkel Topping �Group plc (AIM: FEN).

22 October 2014  •  Read more

Walbrook PR appointed as financial PR to SyQic plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR advisor to AIM listed media and technology company SyQic plc (AIM: SYQ).

08 September 2014  •  Read more

Walbrook PR appointed as financial PR to Optibiotix Health plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR advisor to AIM listed healthcare company OptiBiotix Health plc (AIM: OPTI) following it move to AIM and IPO. Walbrook is ranked No.1 for Healthcare in the AIM Advisers Rankings Guide.

04 August 2014  •  Read more

Walbrook PR appointed as financial PR to EMED Mining

Walbrook PR has been appointed by EMED Mining Public Limited (the "Company") (AIM: EMED), the Europe-based minerals development and exploration company, to manage communications with the financial media, research analysts and investors.

08 July 2014  •  Read more

Walbrook PR appointed as financial PR to ACTA S.P.A

Walbrook PR has been appointed by Acta plc (AIM: ACTA), a hydrogen energy company providing a lowest-cost solution for the onsite production of hydrogen, to manage communications with the financial media, research analysts and investors. Walbrook's account team will be Bob Huxford, Paul Cornelius and Nick Rome.

25 June 2014  •  Read more

mirada - client win

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR advisor to mirada plc, the AIM-quoted audio-visual technology specialist.

24 June 2014  •  Read more

Walbrook hires Sam Allen

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces that Sam Allen has joined the Walbrook team as an Associate to support the continuing growth of the business.

01 May 2014  •  Read more

Walbrook hires Nick Rome

Walbrook PR announces that Nick Rome has joined the Walbrook team as a Senior Associate to support the continuing growth of the business.

15 April 2014  •  Read more

Advanced Oncotherapy plc client win

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR advisor to AIM listed healthcare company Advanced Oncotherapy plc (AIM: AVO). Walbrook is ranked No.1 for Healthcare in the AIM Advisers Rankings Guide.

21 March 2014  •  Read more

Daily Internet plc client win

Walbrook PR has been appointed by Daily Internet plc (AIM: DAIP), the hosting and cloud infrastructure provider, to manage communications with the financial media, research analysts and investors. Walbrook's account team will be Bob Huxford, Guy McDougall and Paul Cornelius.

03 February 2014  •  Read more

Walbrook PR appointed as financial PR to Collagen Solutions plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR advisor to AIM listed healthcare company Collagen Solutions plc (AIM: COS). Walbrook is ranked No.1 for Healthcare in the AIM Advisers Rankings Guide.

02 January 2014  •  Read more

2013

Walbrook PR client wins the outstanding Achievement Award

Walbrook PR announces that EKF Diagnostics, the AIM listed point-of-care diagnostics business, won the Outstanding Achievement Award at this year's MediWales Innovation Awards. The award recognises the sustainable growth the Company has achieved throughout the year.

18 December 2013  •  Read more

Walbrook PR advises Arria NLG PLC on its successful admission to AIM

Walbrook PR has been appointed by Arria NLG Plc ("Arria"), a leader in the development and deployment of Natural Language Generation ("NLG") technologies, to manage communications with the financial media, research analysts and investors surrounding its Admission to AIM announced Thursday 5th December 2013. The account is being led by Walbrook's Head of Technology Sector, Bob Huxford.

10 December 2013  •  Read more

Walbrook PR maintains No.1 spot for AIM healthcare

Walbrook announces that it has been ranked no. 1 Financial PR for Healthcare in the most recent AIM Advisers Rankings Guide, for the second consecutive quarter.

15 November 2013  •  Read more

Great Western Mining Corporation client win

Walbrook PR has been appointed by Great Western Mining Corporation Plc ("Great Western" or the "Company"), the Nevada based mineral exploration Company, to manage communications with the financial media, research analysts and investors. Walbrook's account team will be Paul Cornelius and Guy McDougall.

14 October 2013  •  Read more

Mobile Tornado Group client win

Walbrook PR announced its appointment as Financial PR advisor to Mobile Tornado Group plc, the Instant Communications services provider for mobile devices.

03 October 2013  •  Read more

Walbrook PR appointed as financial PR to Avacta Group

Walbrook PR announces its appointment as Financial PR advisor to AIM listed healthcare company Avacta Group plc (AIM: AVCT). Walbrook now acts for 14 AIM listed healthcare companies and is ranked No.1 for Healthcare in the AIM Advisers Rankings Guide.

27 September 2013  •  Read more

Walbrook PR advises RapidCloud International plc on successful Aim IPO

Walbrook PR has been appointed by RapidCloud International Plc ("RapidCloud"), the computing services, web hosting and web solutions provider based in Southeast Asia, to manage communications with the financial media, research analysts and investors following its Placing to raise £1.0m and Admission to AIM announced last week. The account will be headed up by Walbrook's Head of Technology Sector, Bob Huxford.

20 August 2013  •  Read more

Lifeline Scientific client win

Walbrook PR is pleased to announce its appointment as Financial PR advisor to Lifeline Scientific Inc, the Chicago based organ, tissue and cell transplantation company.

12 July 2013  •  Read more

LiDCO Group Client Win

Walbrook PR is pleased to announce its appointment as Financial PR advisor to LiDCO Group Plc, the cardiovascular monitoring company.

03 June 2013  •  Read more

Walbrook PR advises on AIM IPO Satellite Solutions Worldwide Group plc

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to Satellite Solutions Worldwide Group plc ("SSW") having worked on the Company's recent IPO which raised £2.25m and saw the satellite broadband business join AIM with an initial valuation of just under £14m. Walbrook will manage communications with the financial media, research analysts and investors on behalf of SSW.

03 June 2013  •  Read more

Cambridge Cognition client win

Walbrook PR are pleased to announce its appointment as Financial PR advisor to Cambridge Cognition Holdings Plc , to manage communications with the financial media, research analysts and investors surrounding its Placing to raise £6.4m and Admission to AIM this morning. This is the third AIM IPO in the healthcare sector advised by Walbrook PR in the last four months.

18 April 2013  •  Read more

Health Investment Opportunity client win

Walbrook PR are pleased to announce its appointment as Financial PR advisor to Healthcare Investment Opportunities Plc , to manage communications with the financial media, research analysts and investors surrounding its Placing to raise £4m and Admission to AIM this morning.

05 April 2013  •  Read more

Walbrook New Hires

Walbrook PR is pleased to announce that Anna Dunphy and Mike Wort have joined the team as Senior Associates, strengthening its leading position in the Life Sciences and Renewable Energy sectors.

25 March 2013  •  Read more

TyraTech plc client win

Walbrook PR announces its appointment as Financial Public Relations advisor to TyraTech Inc (AIM: TYR and TYRU), the natural life sciences Company focussed on effective and safe insect and parasite control technologies.

19 March 2013  •  Read more

Walbrook New Hire

Walbrook is pleased to announce that Guy McDougall has joined the Walbrook team.

08 March 2013  •  Read more

Cyan Holdings client win

Walbrook PR are pleased to announce its appointment as Financial PR advisor to Cyan Holdings plc, the provider of flexible wireless solutions for utility metering and lighting control.

17 January 2013  •  Read more

2012

LiteBulb Group client win

Walbrook PR are pleased to announce its appointment as Financial PR advisor to LiteBulb Group Ltd, an AIM listed business that identifies, engineers, manufactures and distributes innovative branded consumer products.

10 December 2012  •  Read more

Walbrook PR client wins The Entrepreneur of the Year Award

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces that Julian Baines the Chief Executive of EKF Diagnostics, a worldwide manufacturer of point of care in-vitro diagnostics devices, won The Entrepreneur of the Year Award at this year's IWA Business Awards. This award recognises the outstanding achievement of an individual at the forefront of business activity in Wales, who has demonstrated conspicuous entrepreneurship within their business and/or in the wider business community.

09 November 2012  •  Read more

Venn Life Sciences client win

Walbrook PR are pleased to announce its appointment as Financial PR advisor to Armscote Investment Company Plc, to manage communications with the financial media, research analysts and investors surrounding its acquisition of Venn Life Sciences Ltd, Placing to raise £2.5m and admission to AIM.

08 November 2012  •  Read more

Walbrook PR client wins the Best Use of AIM Award

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces that one of its clients, EKF Diagnostics, won the Best Use of AIM Award at this year's AIM Awards Dinner. The AIM Awards highlight those companies listed on the London Stock Exchange's Alternative Investment Market that have stood out as the stars over the last 12 months.

26 October 2012  •  Read more

Walbrook PR clients shortlisted for AIM Awards

Walbrook PR announces that two of its clients have been shortlisted for the forthcoming AIM Awards to be held next month.

10 September 2012  •  Read more

Ideagen client win

Ideagen plc (AIM: IDEA), a leading supplier of Compliance based Enterprise Information Management, announces that it has appointed Walbrook PR Ltd as its Financial PR advisor. Walbrook will advise Ideagen on its communications with the financial media, research analysts and other small cap investor groups in London and the regions, following its admission to AIM last month.

16 August 2012  •  Read more

Walbrook Morningstar AIM Rankings (Q3 2012)

Walbrook PR, which provides Financial PR and Investor Relations to Small Cap and AIM listed companies, announces further progression in the Morningstar AIM Rankings and is now ranked joint 1st in Healthcare.

01 August 2012  •  Read more

Eden Research client win

Eden Research plc (AIM: EDEN), the agrochemical and encapsulation development company, announces that it has appointed Walbrook PR Ltd as its Financial PR advisor. Walbrook will advise Eden Research on its communications with the financial media, research analysts and other small cap investor groups in London and the regions, following its admission to AIM on Friday 11 May 2012.

15 May 2012  •  Read more

Astar Minerals client win

Astar Minerals plc (AIM: ASTA) - formerly Pan Pacific Aggregates Ltd - the British Columbia based aggregates company, has appointed Walbrook PR Ltd as its Financial PR advisor. Walbrook will advise Astar Minerals on its communications with the financial media, research analysts and other small cap investor groups in London and the regions.

26 March 2012  •  Read more

Surgical Innovations client win

Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of creative solutions for minimally invasive surgery, has appointed Walbrook PR Ltd as its Financial PR advisor. Walbrook will advise Surgical Innovations on its communications with the financial media, research analysts and other small cap investor groups in London and the regions.

23 March 2012  •  Read more

2011

Walbrook PR in Top 50 movers & shakers for growth companies

Walbrook PR, which provides Financial PR and Investor Relations to Small Cap and AIM listed companies, announces that Paul McManus, Director and Founder of Walbrook, has featured in the Growth Company Investor in the Top 50 Movers & Shakers, a definitive annual list of the most important people in the growth company sector, for the second year running.

21 December 2011  •  Read more

Ilika client win

Ilika plc (AIM: IKA), the advanced cleantech materials discovery company, has appointed Walbrook PR Ltd as its Financial PR advisor. Walbrook will advise Ilika on its communications with the financial media, research analysts and other small cap investor groups in London and the regions.

18 October 2011  •  Read more

Walbrook PR wins Boomerang Plus account

Boomerang Plus (AIM: BOOM), the profitable media investment group, has appointed Walbrook PR Ltd as its Financial PR advisor.

29 June 2011  •  Read more

Corero client win

Corero plc (AIM: CORO.L), the AIM listed network security and business software provider, has appointed Walbrook PR Ltd as its Financial PR and IR advisor.

09 June 2011  •  Read more

Energetix client win

Energetix (AIM: EGX.L), which develops and commercialises alternative and efficient energy products, has appointed Walbrook PR Ltd as its Financial PR and IR advisor.

13 May 2011  •  Read more

Walbrook joins the Epistem Team

Epistem (AIM: EHP.L), the leading UK biotechnology and contract research company, has appointed Walbrook PR Ltd as part of its Financial PR and IR advisory team.

05 May 2011  •  Read more

Walbrook Hemscott AIM Rankings (Q1 2011)

Walbrook PR, which provides Financial PR and Investor Relations to Small Cap and AIM listed companies, announces further progression in the Hemscott AIM Rankings.

01 February 2011  •  Read more

2010

Western Mail Article

Walbrook PR, which provides Financial PR and Investor Relations to Small Cap and AIM listed companies, announces that Paul Cornelius, Director and Head of Investor Relations at Walbrook, recently featured in the Business in Wales, Wales Top 300 supplement, writing on why AIM is an attractive way for Welsh Companies to get access to primary capital.

23 December 2010  •  Read more

Lipoxen client win

Lipoxen (AIM: LPX.L), the leading UK biopharmaceutical company providing specialist delivery solutions to improve the efficacy and performance of drugs and vaccines, has appointed Walbrook PR Ltd as its financial PR and IR advisor.

17 November 2010  •  Read more

Walbrook New Hire

Walbrook PR, which provides Financial PR and Investor Relations to Small Cap and AIM listed companies, announces that Dr Paul Cornelius (ex-finnCap) has joined the Walbrook team.

03 November 2010  •  Read more

First Derivatives client win

First Derivatives (AIM: FDP.L, IEX: GYQ.I), the provider of software and support services to the investment banking market and derivatives technology industry, has appointed Walbrook PR Ltd as its financial PR and IR advisor.

07 October 2010  •  Read more

SQS client win

SQS Software Quality Systems AG (AIM: SQS.L), the world's largest pure play supplier of independent software testing and quality management services has appointed Walbrook PR Ltd as its financial PR and IR advisor.

23 August 2010  •  Read more

Kryso client win

Kryso Resources plc (AIM: KYS), the mineral exploration and development company focused on projects in Tajikistan has appointed Walbrook PR Ltd as its financial PR and IR advisor.

16 August 2010  •  Read more

Q1 update

Walbrook PR, which provides Financial PR and Investor Relations to Small Cap and AIM listed companies, announces that for the 9 months ended 31 December 2009 it produced a modest profit and that trading in the first quarter of the year has been strong. We are also very pleased to announce that Bob Huxford has joined the Walbrook team from technology focussed financial PR firm ICIS.

09 April 2010  •  Read more

Walbrook PR in Top 50 movers & shakers for growth companies

Walbrook PR, which provides Financial PR and Investor Relations to Small Cap and AIM listed companies, announces that Paul McManus, Director and Founder of Walbrook, was recently featured in the Growth Company Investor in the Top 50 Movers & Shakers, a definitive annual list of the most important people in the growth company sector.

01 February 2010  •  Read more

Who We Work With

Polarean Imaging plc Genedrive plc Westminster-Group-plc Tristel-plc Solid-State PCIPal_Logo_Main-CMYK EKF-Diagnostics-Holdings-plc Creo-Medical-logo Pennant-International-plc Van Elle plc amcomri logo

Latest News

Latest Tweets Twitter